Medtronic's EV ICD System Proves Effective in Cardiac Arrhythmia Management: Long-term Study Results
Medtronic plc (NYSE:MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart ...
Medtronic MDT recently declared the findings of its investigational Extravascular Implantable Cardioverter–Defibrillator (EV ICD) Study. These were presented as late-breaking science at Heart Rhythm ...
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. has announced completion of its second human clinical study of the Extravascular Implantable Cardioverter Defibrillator (EV-ICD) Lead System ...
Medtronic's extravascular implantable cardioverter-defibrillator (EV-ICD) may have a mermaid's name, but when the company's R&D team began the project, it was another fictional character that came to ...
The novel design of AtaCor's Atala™ lead aims to provide reliable sensing, antitachycardia pacing (ATP), and shock therapies with no hardware placed in the heart or vasculature SAN CLEMENTE, Calif., ...
Medtronic MDT recently declared the findings of its investigational Extravascular Implantable Cardioverter–Defibrillator (EV ICD) Study. These were presented as late-breaking science at Heart Rhythm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results